Keywords: efavirenz; α; apha; ALT; alanine aminotransferase; ANOVA; analysis of variance; AST; aspartate transaminase; β; beta; cART; combination antiretroviral therapy; C; control; DAB; liquid 3âµ3-diaminobenzidine; DPX; distyrene/plasticizer/xylene; EFV; efavirenz; eGFR;
مقالات ISI efavirenz (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: efavirenz; Efavirenz; Stress testing; Degradation products; Mass spectrometry; NMR spectrometry;
Keywords: efavirenz; Overweight; Body composition; Antiretroviral drugs; Drug monitoring; Efavirenz; Atazanavir; Darunavir;
Keywords: efavirenz; ABPAS; alcian blue periodic acid schiff; ABAF; alcian blue aldehyde fuschin; ART; antiretroviral therapy; C; control; EFV; efavirenz; FTC; emtricitabine; HCD; high calorie diet; TDF; tenofovir disoproxil fumarate; Antiretroviral treatment; Biofilm; Obesit
Keywords: efavirenz; Solid dispersions; Ritonavir; Efavirenz; Nanoparticles; Precipitation; Solubility;
Keywords: efavirenz; efavirenz; 1H NMR; 13C CPMAS NMR; polymorphism;
Keywords: efavirenz; HIV; Pharmacogenetics; Efavirenz; Premature discontinuation
Keywords: efavirenz; 3TC; Lamivudine; ABC; Abacavir; ARV; Antiretroviral; ATV; Atazanavir; AZT; Zidovudine; d4T; Stavudine; DRV; Darunavir; EFV; Efavirenz; FTC; Emtricitabine; L&D; Labor and delivery; LOQ; Limit of quantification; LPV; Lopinavir; M8; NFV hydroxy-tert-butylami
Keywords: efavirenz; HIV; Efavirenz; SLN; HIV associated dementia; BBB; Phenylalanine;
Keywords: efavirenz; anemia; bilirubin disposition; drug interactions; efavirenz; monotherapy; neutropenia
Keywords: efavirenz; Efavirenz; Isoniazid; Mitochondria; Complex I; Drug-induced liver injury (DILI); Hepatotoxicity; Methylene blue; Peroxynitrite1-ABT, 1-aminobenzotriazole; BNPP, bis-p-nitrophenyl phosphate; CBA, coumarin-7-boronic acid; CYP, cytochrome P450; EFV, efaviren
Keywords: efavirenz; Neuropsychiatric impairment; Efavirenz; Continuous time Markov model; NONMEM; Monte Carlo simulation; Duration of NPI
Keywords: efavirenz; HIV; cART; Efavirenz; Late presenters; Efficacy
Development and validation of analytical method for quantitation of Emtricitabine, Tenofovir, Efavirenz based on HPLC
Keywords: efavirenz; Emtricitabine; Tenofovir; Efavirenz; Antiretrovirals; HPLC-UV;
Impact of dolutegravir and efavirenz on immune recovery markers: results from a randomized clinical trial
Keywords: efavirenz; Antiretroviral therapy; CD4 percentage; CD4 T-cell count; CD4/CD8 ratio; dolutegravir; efavirenz;
Functional characterization of 40 CYP2B6 allelic variants by assessing efavirenz 8-hydroxylation
Keywords: efavirenz; Efavirenz (PubChem CID: 64139); 8-Hydroxyefavirenz (PubChem CID: 487643); 7-Ethoxy-4-trifluorometylcoumarin (PubChem CID: 24869840); 7-Hydroxy-4-trifluoromethylcoumarin (PubChem CID: 24862915); Dimanganese decacarbonyl (PubChem CID: 517769); Sodium hydros
Unraveling the binding characteristics of the anti-HIV agents abacavir, efavirenz and emtricitabine to bovine serum albumin using spectroscopic and molecular simulation approaches
Keywords: efavirenz; Abacavir; Efavirenz; Emtricitabine; Serum albumin; Fluorescence quenching; Molecular docking;
DFT study of nanotubes as the drug delivery vehicles of Efavirenz
Keywords: efavirenz; Efavirenz; Boron nitride nanotubes; Carbon nanotubes; DFT; Drug delivery;
Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors
Keywords: efavirenz; Anti-HIV; CD4+ T cell-line; Efavirenz; Naphthoxazine derivatives;
Host-guest interaction study of Efavirenz with hydroxypropylâβâcyclodextrin and lâarginine by computational simulation studies: Preparation and characterization of supramolecular complexes
Keywords: efavirenz; Efavirenz; Solubility enhancement; Inclusion complex;
Lipid based delivery of Efavirenz: An answer to its erratic absorption and food effect
Keywords: efavirenz; Efavirenz; Antiretroviral; Isotropic mixture; Food effect; Oral bioavailability;
Development and validation of a liquid chromatography-MS/MS method for simultaneous quantification of tenofovir and efavirenz in biological tissues and fluids
Keywords: efavirenz; Tenofovir; Efavirenz; Antiretrovirals; Intravaginal administration; Pre-exposure prophylaxis;
A histomorphometric study on the effects of antiretroviral therapy (ART) combined with a high-calorie diet (HCD) on aortic perivascular adipose tissue (PVAT)
Keywords: efavirenz; BAT; brown adipose tissue; C; control; EFV; Efavirenz; FTC; Emtricitabine; HCD; high calorie diet; PVAT; perivascular adipose tissue; TDF; Tenofovir Disoproxil Fumarate; WAT; white adipose tissue; Aortic wall thickness; PVAT sizes; Adipocytes; Leptin inte
Universal efavirenz determination in transport study, rat placenta perfusion and placenta lysate by HPLC-UV
Keywords: efavirenz; Efavirenz; Drug transporters; Drug-drug interactions; Liquid chromatography; Pharmacokinetics; Stability;
Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance
Keywords: efavirenz; ART; antiretroviral therapy; TasP; Treatment-as-Prevention; NRTI; nucleoside reverse transcriptase (RT) inhibitor; NNRTI; non-nucleoside RT inhibitor; PI; protease inhibitor; INSTI; integrase strand transfer inhibitor; RAL; raltegravir; EVG; elvitegravir;
HIV antiretroviral drug Efavirenz induces anxiety-like and depression-like behavior in rats: evaluation of neurotransmitter alterations in the striatum
Keywords: efavirenz; Antiretroviral drugs; Efavirenz; Neuropsychiatric adverse events; Monoamines; Neurotransmitters; Striatum;
Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects
Keywords: efavirenz; HIV; Efavirenz; Toxicity; Antiretroviral therapy; Mechanisms; Adverse effects;
The dual modulatory effects of efavirenz on GABAA receptors are mediated via two distinct sites
Keywords: efavirenz; Recombinant GABAA receptors; Adverse CNS side effects; Picrotoxin; AIDS; Antiretroviral; BDZ; benzodiazepine; CNS; central nervous system; DMSO; dimethyl sulfoxide; DZ; diazepam; EFAV; efavirenz; FLU; flumazenil; LGICs; ligand-gated ion channels; HEK293;
Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease
Keywords: efavirenz; CYP46A1; Efavirenz; Alzheimer's disease; 24-Hydroxycholesterol; Amyloid; Cholesterol;
Development of efavirenz loaded solid lipid nanoparticles: Risk assessment, quality-by-design (QbD) based optimisation and physicochemical characterisation
Keywords: efavirenz; Solid lipid nanoparticles; Efavirenz; Quality-by design; Nanoprecipitation; Anti-HIV drugs;
Challenges in assignment of allosteric effects in cytochrome P450-catalyzed substrate oxidations to structural dynamics in the hemoprotein architecture
Keywords: efavirenz; Cytochrome P450; Allosteric effects; Cooperativity; Key determinants; Molecular modeling; 1PB; 1-pyrenebutanol; 4MP; 4-methylpyrazole; 7BQ; 7-benzyloxyquinoline; 7EC; 7-ethoxycoumarin; 7EFC; 7-ethoxy-4-trifluoromethylcoumarin; 9AP; 9-aminophenanthrene; 9E
Possible anti-depressant effect of efavirenz and pro-depressive-like effect of voriconazole in specified doses in various experimental models of depression in mice
Keywords: efavirenz; Efavirenz; Voriconazole; Depression; Mice;
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort
Keywords: efavirenz; HIV; Cardiovascular risk; Atherosclerosis; Darunavir; Atazanavir; Efavirenz;
Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation
Keywords: efavirenz; EFV; efavirenz; NNRTI; non-nucleoside reverse transcriptase inhibitor; HIV-1/AIDS; human immunodeficiency virus type 1 infection; SLS; sodium lauryl sulfate; HPC; hydroxypropylcellulose; HPMC; hydroxypropylmetilcellulose; NRTIs; nucleoside reverse transcr
Predicting CD4 count changes among patients on antiretroviral treatment: Application of data mining techniques
Keywords: efavirenz; CD4 count change; Antiretroviral treatment; Computational methods; Random Forest; Neural Network; J48, Decision tree; ABC; Abacavir; ddI; Didanosine; d4T; Stavudin; EFV; Efavirenz; FTC; Emotricitabine; LPV/r; Lopinavir/ritonavir; NFV; Nelfinavir; NNRTI; N
New solid forms of efavirenz: Synthesis, vibrational spectroscopy and quantum chemical calculations
Keywords: efavirenz; Efavirenz; Vibrational spectroscopy; Quantum chemical methods;
Sex-by-formulation interaction assessed through a bioequivalence study of efavirenz tablets
Keywords: efavirenz; Sex-by-formulation interaction; Bioequivalence; In vitro-in vivo correlation; Efavirenz;
Significant intolerability of efavirenz in HIV occupational postexposure prophylaxis
Keywords: efavirenz; Postexposure prophylaxis; Tolerability; Occupational exposure; HIV infection; Efavirenz
A combined TD-DFT and spectroscopic investigation of the solute–solvent interactions of efavirenz
Keywords: efavirenz; Efavirenz; TD-DFT calculations; UV–visible spectrophotometry; 1H NMR spectroscopy; Polarity; Hydrogen bonding
Preparation and characterization of Efavirenz nanosuspension with the application of enhanced solubility and dissolution rate
Keywords: efavirenz; Efavirenz; Bioavailability; Nanosuspension; Mathematical model; Dissolution efficiency;
Effect of mid-dose efavirenz concentrations and CYP2B6 genotype on viral suppression in patients on first-line antiretroviral therapy
Keywords: efavirenz; Virological failure; Therapeutic drug monitoring; Pharmacokinetic; Pharmacogenetic; Efavirenz; CYP2B6
Short communicationImpact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokines
Keywords: efavirenz; Adipocyte; Elvitegravir; Efavirenz; Lipodystrophy; Adipokine; Cytokine;
Efavirenz biotransformation as an up-stream event of mood changes in HIV-infected patients
Keywords: efavirenz; EFV; efavirenz; cART; combined antiretroviral therapy; CNS; central nervous system; CSF; cerebrospinal fluid; CYP; cytochrome P450; UGT; UDP-glucuronosyltransferase; 8-OH-EFV; 8-hydroxy-efavirenz; 7-OH-EFV; 7-hydroxy-efavirenz; 8,14-diOH-EFV; , 8,14-dihyd
Mixed surfactant based (SNEDDS) self-nanoemulsifying drug delivery system presenting efavirenz for enhancement of oral bioavailability
Keywords: efavirenz; SNEDDS; Mixed surfactants; Efavirenz; FT-IR; In vivo bioavailability
Development of efavirenz cocrystals from stoichiometric solutions by spray drying technology
Keywords: efavirenz; Efavirenz; Glutaric acid; Cocrystals; Spray drying
Rifampin enhances cytochrome P450 (CYP) 2B6-mediated efavirenz 8-hydroxylation in healthy volunteers
Keywords: efavirenz; Rifampin; Efavirenz; 8-Hydroxylation; CYP2B6; Induction; In vivo probe;
Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry
Keywords: efavirenz; AIDS; Efavirenz; Reverse transcriptase; Structure-activity relationship; Synthesis; HIV; NNRTIs;
Insights into CYP2B6-mediated drug-drug interactions
Keywords: efavirenz; CAR; constitutive androstane receptor; C/EBP; CCAAT/enhancer-binding protein; CHOP; cyclophosphamide-doxorubicin-vincristine-prednisone; CITCO; (6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-(3,4-dichlorobenzyl)oxime); COUP-TF; chic
Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: A QbD approach
Keywords: efavirenz; Efavirenz; Soluplus®; HPMCAS-HF; Hot melt extrusion; Solubility; FTIR imaging;
ReviewPharmacogenetics of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in resource-limited settings: Influence on antiretroviral therapy response and concomitant anti-tubercular, antimalarial and contraceptive treatments
Keywords: efavirenz; Drug-drug interactions; Efavirenz; HIV; Nevirapine; Pharmacogenetics; Resource-limited countries;